Sonoma Pharmaceuticals (SNOA) awards 10,000 stock options to board director Weigerstorfer
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Sonoma Pharmaceuticals, Inc. director Philippe Weigerstorfer received a grant of stock options for 10,000 shares of common stock at an exercise price of $1.2600 per share. The options vest in three equal installments on July 9, 2027, July 9, 2028, and July 9, 2029, or upon a change of control. Following this award, he holds 30,001 stock options directly, expiring on July 9, 2036, as compensation for his Board service.
Positive
- None.
Negative
- None.
Insights
Director received routine stock option compensation, no open-market trading.
Director Philippe Weigerstorfer was granted stock options for 10,000 shares of Sonoma Pharmaceuticals common stock at an exercise price of $1.2600 per share. This is coded as a grant/award, not a market purchase or sale.
The options vest one-third annually on July 9, 2027, July 9, 2028, and July 9, 2029, or upon a change of control, aligning his incentives with longer-term company performance. After the grant, he directly holds 30,001 options expiring on July 9, 2036, indicating continued equity-based compensation rather than a change in ownership through trading.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Weigerstorfer Philippe
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock option (right to buy) | 10,000 | $0.00 | -- |
Holdings After Transaction:
Stock option (right to buy) — 30,001 shares (Direct, null)
Footnotes (1)
- The options vest one third each on 7/9/2027, 7/9/2028 and 7/9/2029, or upon change of control. The options were awarded and granted to Mr. Weigerstorfer for services performed on the Board of Directors.
Key Figures
Options granted: 10,000 stock options
Exercise price: $1.2600 per share
Total options after grant: 30,001 stock options
+2 more
5 metrics
Options granted
10,000 stock options
Grant of stock options to director on July 9, 2026
Exercise price
$1.2600 per share
Exercise price of options granted to director
Total options after grant
30,001 stock options
Director’s stock option holdings following the transaction
Expiration date
July 9, 2036
Expiration of the granted stock options
Vesting schedule
One third on 7/9/2027, 7/9/2028, 7/9/2029
Time-based vesting of the stock option grant
Key Terms
stock option, exercise price, change of control, vesting
4 terms
stock option financial
"The options were awarded and granted to Mr. Weigerstorfer"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price": "1.2600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
change of control financial
"or upon change of control."
A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.
vesting financial
"The options vest one third each on 7/9/2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What transaction did Sonoma Pharmaceuticals (SNOA) report for Philippe Weigerstorfer?
Sonoma Pharmaceuticals reported that director Philippe Weigerstorfer received a grant of 10,000 stock options to purchase common stock. The grant is compensation for his service on the Board of Directors.
What is the exercise price of the new stock options granted to the Sonoma Pharmaceuticals (SNOA) director?
The stock options granted to director Philippe Weigerstorfer have an exercise price of $1.2600 per share. This price is the cost per share he must pay to exercise the options.
How and when do the Sonoma Pharmaceuticals (SNOA) options granted to Philippe Weigerstorfer vest?
The options vest in three equal installments, one third each on July 9, 2027, July 9, 2028, and July 9, 2029, or upon a change of control of Sonoma Pharmaceuticals.
What is the expiration date of the Sonoma Pharmaceuticals (SNOA) options granted to the director?
The stock options granted to director Philippe Weigerstorfer expire on July 9, 2036. After this date, any unexercised options from this grant will no longer be exercisable.
How many Sonoma Pharmaceuticals (SNOA) stock options does Philippe Weigerstorfer hold after this grant?
After this grant, director Philippe Weigerstorfer holds a total of 30,001 stock options directly. This figure represents his stock option holdings following the reported transaction.